N/A
N=60
Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration
Postoperative Pain
Bottom Line
View on ClinicalTrials.gov: NCT02658240 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Nov 2018
Primary outcome: Primary: Postoperative Pain Score at Resting — 1; 2 units on a scale — p=0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ropivacaine (Drug); Epinephrine (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Texas Southwestern Medical Center
- Primary completion
- Nov 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Postoperative Pain Score at Resting |
1; 2 | 0.05 |
| PRIMARY Postoperative Pain Score With Movement |
3; 4 | 0.05 |
| SECONDARY Oral Morphine Equivalents of Postoperative Opioid Requirements for 48 Hours |
101.0; 115.6 | 0.149 |
| SECONDARY The Time to Ambulation |
21.3; 22 | 0.584 |
Summary
This randomized, controlled, observer-blinded study clinical trial was designed to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty.
Eligibility Criteria
Inclusion Criteria
- Female ASA physical status 1-3 scheduled for total hip arthroplasty
- Age 18-80 years old
- Able to participate personally or by legal representative in informed consent in English or Spanish
Exclusion Criteria
- History of relevant drug allergy
- Age less than 18 or greater than 80 years
- Chronic opioid use or drug abuse
- Significant psychiatric disturbance
- Inability to understand the study protocol
- Refusal to provide written consent
Data sourced from ClinicalTrials.gov (NCT02658240). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.